In the current month, USNA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. USNA average Analyst price target in the last month is 25.000.
Based on analysts' estimates, USNA EPS is projected to reach 0.090 in FY2026Q3, following reported EPS of -1.157 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -1.16, while USANA Health Sciences IncUSNA's earnings per share (EPS) for the previous quarter was USD 0.41. EPS for the next quarter is expected at USD 0.09.